Company intelligence / Profile preview

American Screening

Shreveport, Louisiana, United Statesamericanscreeningcorp.com ↗

Ownership: Private
Development stage: Other

Overview

American Screening is a leading U.S.-based ISO 13485-certified manufacturer and distributor of rapid diagnostic tests for drugs of abuse and alcohol. The company also offers COVID‑19 rapid antibody tests. Its products are FDA-cleared and CE-marked for global distribution. No clinical trial results are reported as the products are diagnostics rather than therapeutics[1][2][3][6].

Therapeutic areas: PsychiatryInfectious DiseasesOther
Modalities: DeviceDiagnostic test
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on American Screening.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American Screening.

Explore the full profile